Correvio Pharma Corp.. (CORV) NASDAQ
$0.42 0 (0.00%)
Market Cap: $27.80M
As of 05/26/20 12:00 AM EDT. Market closed.

Correvio Pharma Corp.. (CORV)
NASDAQ
$0.42
0 (0.00%)
Market Cap: $27.80M
As of 05/26/20 12:00 AM EDT. Market closed.
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat ... read more
Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. read less